Literature DB >> 318226

In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.

V L Sutter1, B Kirby, S M Finegold.   

Abstract

The in vitro activity of cefoxitin against 221 recent isolates of anaerobic bacteria was compared with that of cefamandole and cefuroxime by the agar dilution technique. At achievable serum levels of 32 micrograms/ml, all three drugs were active against most groups of anaerobic bacteria tested. Cefoxitin was active against most strains of the Bacteroides fragilis group, whereas cefamandole and cefuroxime were relatively ineffective. Cefoxitin was least active against Clostridium species other than Clostridium perfringens, whereas cefamandole was very active and cefuroxime moderately active. A review of recent in vitro studies with cefoxitin and parenterally administered cephalosporins indicates that cefoxitin is the most active compound against the B. fragilis group and is least active against Clostridium species other than C. perfringens.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 318226     DOI: 10.1093/clinids/1.1.218

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  4 in total

1.  National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.

Authors:  W J Brown
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

3.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

4.  Concentrations of cefoxitin in gallbladder bile of cholecystectomy patients.

Authors:  J F Hansbrough; J E Clark
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.